Keyur B. Shah

Keyur B. Shah

Advanced Heart Failure and Transplant Cardiology | Cardiology

417 N 11th St
Richmond, VA 23298

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 141 publications

Comparative Outcomes of Direct Impella Use vs. Intra-Aortic Balloon Pump (IABP)-to- Impella Escalation Strategy in Cardiogenic Shock: Insights from the National Inpatient Sample.

Comparative Outcomes of Direct Impella Use vs. Intra-Aortic Balloon Pump (IABP)-to- Impella Escalation Strategy in Cardiogenic Shock: Insights from the National Inpatient Sample.

Journal: Research square

Published: July 17, 2026

Donor-Derived Cell-Free DNA Stratifies Risk of Mortality and Graft Dysfunction in Severe Acute Cardiac Allograft Rejection.

Donor-Derived Cell-Free DNA Stratifies Risk of Mortality and Graft Dysfunction in Severe Acute Cardiac Allograft Rejection.

Journal: Circulation. Heart failure

Published: June 15, 2026

Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM.

Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM.

Journal: European journal of heart failure

Published: June 15, 2026

Comparative outcomes of intra-aortic balloon pump versus impella in non-myocardial infarction cardiogenic shock: A National Inpatient Sample Database analysis.

Comparative outcomes of intra-aortic balloon pump versus impella in non-myocardial infarction cardiogenic shock: A National Inpatient Sample Database analysis.

Journal: JHLT open

Published: June 03, 2026

Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial.

Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial.

Journal: JAMA cardiology

Published: March 30, 2026

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Journal: The American journal of cardiology

Published: January 26, 2026

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy.

Journal: The American journal of cardiology

Published: January 26, 2026

Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAs.

Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAs.

Journal: Circulation. Heart failure

Published: January 12, 2026

A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.

A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.

Journal: Future cardiology

Published: December 12, 2025

Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension.

Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension.

Journal: JAMA cardiology

Published: November 08, 2025

Optimization of pretransplant amiodarone therapy to prevent primary graft dysfunction following heart transplantation.

Optimization of pretransplant amiodarone therapy to prevent primary graft dysfunction following heart transplantation.

Journal: JHLT open

Published: October 27, 2025

Biventricular impella support in acute antibody-mediated cardiac allograft rejection with severe hemodynamic compromise.

Biventricular impella support in acute antibody-mediated cardiac allograft rejection with severe hemodynamic compromise.

Journal: Journal of cardiothoracic surgery

Published: October 17, 2025

Showing 1-12 of 141

Last Updated: 09/26/2026